
Intech Lifesciences Private Limited
Founded in 2011 and headquartered in Delhi, India.
Founded in 2011 and headquartered in Delhi, India.
Delhi, India
+91-XXXXXXXXXX
U33110DL2011PTC218038
218038
Private Limited Indian Non-Government Company
25 Apr 2011
30 Sep 2015
31 Mar 2015
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rajnesh Airey ![]() | Director | 20-Jun-2012 | Current |
Sarbjit Singh ![]() | Director | 20-Jun-2012 | Current |
Enhance accessibility to Intech Lifesciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Intech Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Sarbjit Singh is a mutual person
Sarbjit Singh is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Intech Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Intech Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intech Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Intech Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2015 as per latest MCA records.
Intech Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2015 with Roc Delhi.
Rajnesh Kumar Airey was appointed as a Director was appointed as a Director on 20 Jun 2012 & has been associated with this company since 12 years 9 months .
Sarbjit Bedi Singh was appointed as a Director was appointed as a Director on 20 Jun 2012 & has been associated with this company since 12 years 9 months .
Intech Lifesciences Private Limited was registered on 25 Apr 2011 with Roc Delhi & aged 13 years 10 months as per MCA records.
Intech Lifesciences Private Limited was incorporated on 25 Apr 2011.
The authorized share capital of Intech Lifesciences Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.15 M.
Currently 2 directors are associated with Intech Lifesciences Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Intech Lifesciences Private Limited is Shop No 6 Neelkanth Apartment Sector 13, Rohini India, New Delhi, 110085.
The corporate identification number (CIN) of Intech Lifesciences Private Limited is U33110DL2011PTC218038 and the company number is 218038 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Intech Lifesciences Private Limited was filed with the ROC on 31 Mar 2015.
Search company & director profiles for free and gain access to critical business data.
RG
NK
MS